IVZ vs MRSN · rev $3.57B vs rev $40.5M
Invesco Plc (IVZ) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
IVZ currently screens at market cap $12.76B. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the IVZ and MRSN stock pages for the full models.
Not investment advice.